Home › Chronische lymfatische leukemie › Ohio › Cincinnati
Chronische lymfatische leukemie klinische studies in Cincinnati, OH
14 studies voor Chronische lymfatische leukemie zoeken deelnemers op locaties in en rond Cincinnati (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- en nog 3
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
RekruterenFase 3
- Oncology Hematology Care Clinical Trials, Llc, Cincinnati
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RekruterenFase 3
- Saint Elizabeth Healthcare ( Site 0041), Edgewood · 8 mijl verwijderd
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruterenFase 4
- Oncology Hematology Care Inc, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruterenFase 3
- University of Cincinnati Medical Center, Cincinnati
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruterenFase 2
- University of Cincinnati, Cincinnati
- Oncology Hematology Care, Fairfield · 15 mijl verwijderd
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
RekruterenFase 1
- University of Cincinnati, Cincinnati
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruterenFase 1
- University of Cincinnati Medical Center, Cincinnati
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruterenFase 2
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 mijl verwijderd
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruterenFase 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University of Cincinnati, Cincinnati
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
RekruterenFase 2
- University of Cincinnati, Cincinnati
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
RekruterenFase 2
- University of Cincinnati, Cincinnati
LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
RekruterenFase 2
- University of Cincinnati Medical Center, Cincinnati
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
RekruterenFase 1/2
- University of Cincinnati, Cincinnati
Chronische lymfatische leukemie studies in andere steden
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
- Nashville, TN13 studies
Andere studies in Cincinnati
- Niet-kleincellige longkanker35 studies
- Kanker (alle vormen)27 studies
- Borstkanker25 studies
- Hartfalen24 studies
- Colorectale kanker21 studies
- Acute myeloïde leukemie20 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Longkanker19 studies
- Obesitas19 studies
- Prostaatkanker18 studies
- Multipel myeloom17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.